Last year, the US Food and Drug Administration (FDA) approved the first and only drug for the treatment of patients 12 years and older with advanced PPGLs that are positive for the norepinephrine ...
Opinions expressed by Forbes Contributors are their own. Dr. Omer Awan is a practicing physician who covers public health. CARLSBAD, CA-NOV 30TH: Mounjaro injection pen on display at Rachel Graham ...
The FDA has approved a new injectable form of the multiple sclerosis drug ocrelizumab for use in adults with relapsing and progressive forms of the disease. Multiple sclerosis occurs when the body ...
The U.S. Food and Drug Administration approved the drug on Thursday, greenlighting the first of a new class of treatments that could help stabilize patients’ symptoms without the uncomfortable ...
The FDA has granted a supplementary approval to Regeneron and Sanofi’s dupilumab (Dupixent) for use as an add-on therapy for inadequately controlled chronic obstructive pulmonary disease (COPD ...
Sept. 27, 2024 – In a breakthrough for people living with schizophrenia, the FDA has approved a new oral medication for adults. Unlike traditional antipsychotic drugs, the medication ...
Sept. 26 (UPI) --The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday. The drug, generically called Cobenfy, is the first oral ...
"This approval offers a new alternative to the antipsychotic medications people with schizophrenia have previously been prescribed." According to the FDA, about 1% of people have schizophrenia ...
director of the FDA's Center for Biologics Evaluation and Research. The vaccine, which was first approved in 2003 to be administered only by healthcare providers, contains a weakened form of live ...
The US Food and Drug Administration has approved Cobenfy ... and constipation. The FDA says people with known liver impairment or moderate to severe kidney impairment should not use the drug.
On Thursday, the FDA approved AbbVie Inc’s (NYSE:ABBV) Vyalev (foscarbidopa and foslevodopa) as the first and only subcutaneous 24-hour infusion of levodopa-based therapy for motor fluctuations ...
The latest in health tech? Apple Watch’s FDA-approved sleep apnea detection feature. Approved for Apple Watch Series 9, Series 10 and Watch Ultra 2, the feature is intended as an OTC risk ...